R

R is a next-generation investigational peptide that acts as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. This unique mechanism positions it as a promising compound in ongoing studies related to metabolic optimization, body composition, and energy regulation. Early research suggests R may support appetite control, insulin sensitivity, and fat metabolism, making it of high interest to providers exploring advanced GLP-based therapies. With its multi-receptor action, R represents a cutting-edge option for clinicians focused on comprehensive metabolic health strategies.